000 01344 a2200421 4500
005 20250517024916.0
264 0 _c20160303
008 201603s 0 0 eng d
022 _a1476-5500
024 7 _a10.1038/cgt.2015.17
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCho, I-R
245 0 0 _aVP2 capsid domain of the H-1 parvovirus determines susceptibility of human cancer cells to H-1 viral infection.
_h[electronic resource]
260 _bCancer gene therapy
_cMay 2015
300 _a271-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
650 0 4 _aAnimals
650 0 4 _aCapsid Proteins
_xgenetics
650 0 4 _aH-1 parvovirus
_xgenetics
650 0 4 _aHeLa Cells
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xgenetics
650 0 4 _aOncolytic Virotherapy
_xmethods
650 0 4 _aParvoviridae Infections
_xvirology
650 0 4 _aRats
650 0 4 _aTransfection
700 1 _aKaowinn, S
700 1 _aSong, J
700 1 _aKim, S
700 1 _aKoh, S S
700 1 _aKang, H-Y
700 1 _aHa, N-C
700 1 _aLee, K H
700 1 _aJun, H-S
700 1 _aChung, Y-H
773 0 _tCancer gene therapy
_gvol. 22
_gno. 5
_gp. 271-7
856 4 0 _uhttps://doi.org/10.1038/cgt.2015.17
_zAvailable from publisher's website
999 _c24788543
_d24788543